{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:29:03Z","timestamp":1792985343532,"version":"4.5.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.alit.2021.11.006","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T17:31:34Z","timestamp":1639416694000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Skin barrier defects in atopic dermatitis: From old idea to new opportunity"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0133-5067","authenticated-orcid":false,"given":"Takeshi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2021.11.006_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.clindermatol.2017.03.005","article-title":"The history of atopic dermatitis","volume":"35","author":"Kramer","year":"2017","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib2","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(00)84844-8","article-title":"A\u00a0clinical and biochemical study of allergy","volume":"212","author":"Barber","year":"1928","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2021.11.006_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJM194505312322203","article-title":"Eczema","volume":"232","author":"Rackemann","year":"1945","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.11.006_bib4","first-page":"441","article-title":"Cutaneous reaction from proteins in eczema","volume":"11","author":"Blackfan","year":"1916","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.alit.2021.11.006_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archderm.1920.02350090094012","article-title":"Protein sensitization in eczema: report of seventy-eight cases","volume":"2","author":"Ramirez","year":"1920","journal-title":"Arch Derm Syphilol"},{"key":"10.1016\/j.alit.2021.11.006_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archderm.1935.01470030093010","article-title":"Evolution of atopic dermatitis","volume":"32","author":"Hill","year":"1935","journal-title":"Arch Derm Syphilol"},{"key":"10.1016\/j.alit.2021.11.006_bib7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/all.12483","article-title":"Tolerance to egg proteins in egg-sensitized infants without previous consumption","volume":"69","author":"Alvaro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaci.2014.08.011","article-title":"Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations","volume":"134","author":"Brough","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2014.10.007","article-title":"Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy","volume":"135","author":"Brough","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/cea.13111","article-title":"Environmental peanut exposure increases the risk of peanut sensitization in high-risk children","volume":"48","author":"Brough","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2133.1980.tb07241.x","article-title":"The 'dry' non-eczematous skin associated with atopic eczema","volume":"103","author":"Finlay","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-6749(83)90546-8","article-title":"Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies","volume":"71","author":"Leung","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib13","first-page":"67","article-title":"Epidermal changes in atopic dermatitis","volume":"114","author":"van Neste","year":"1985","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.alit.2021.11.006_bib14","first-page":"82","article-title":"Clinical and histological features of dry skin in atopic dermatitis","volume":"114","author":"Uehara","year":"1985","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.alit.2021.11.006_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1056\/NEJM198508013130502","article-title":"Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis","volume":"313","author":"Leiferman","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.11.006_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1346-8138.1978.tb01857.x","article-title":"Studies on skin surface barrier functions:--skin surface lipids and transepidermal water loss in atopic skin during childhood","volume":"5","author":"Abe","year":"1978","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2340\/0001555571296300","article-title":"Susceptibility of atopic dermatitis patients to irritant dermatitis caused by sodium lauryl sulphate","volume":"71","author":"Agner","year":"1991","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2021.11.006_bib18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archinte.1944.00210240018004","article-title":"Differential roles of layers of human epigastric skin on diffusion rate of water","volume":"74","author":"Winsor","year":"1944","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.alit.2021.11.006_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/jid.1953.100","article-title":"Further observations on factors which influence the water content of the stratum corneum","volume":"21","author":"Blank","year":"1953","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archderm.1958.01560120030005","article-title":"Location and reformation of the epithelial barrier to water vapor","volume":"78","author":"Monash","year":"1958","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.alit.2021.11.006_bib21","first-page":"26","article-title":"The barrier function in atopic dry skin. Disturbance of membrane-coating granule exocytosis and formation of epidermal lipids?","volume":"176","author":"Fartasch","year":"1992","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.alit.2021.11.006_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2133.1992.tb00118.x","article-title":"Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics","volume":"127","author":"Fartasch","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.1988.tb03262.x","article-title":"Decreased stratum corneum ceramides in atopic individuals--a pathobiochemical factor in xerosis?","volume":"119","author":"Melnik","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1523-1747.ep12470233","article-title":"Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?","volume":"96","author":"Imokawa","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01106105","article-title":"Stratum corneum lipid abnormalities in atopic dermatitis","volume":"283","author":"Yamamoto","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.alit.2021.11.006_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1523-1747.ep12292052","article-title":"Intercellular spaces of the human epidermis as demonstrated with lanthanum","volume":"57","author":"Hashimoto","year":"1971","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1083\/jcb.65.1.180","article-title":"The permeability barrier in mammalian epidermis","volume":"65","author":"Elias","year":"1975","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.alit.2021.11.006_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejcb.2010.07.010","article-title":"Tight junctions form a barrier in human epidermis","volume":"89","author":"Kirschner","year":"2010","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.alit.2021.11.006_bib29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/jid.2012.507","article-title":"Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes","volume":"133","author":"Kirschner","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1083\/jcb.200110122","article-title":"Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice","volume":"156","author":"Furuse","year":"2002","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.alit.2021.11.006_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdermsci.2013.01.002","article-title":"Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice","volume":"70","author":"Sugawara","year":"2013","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib32","doi-asserted-by":"crossref","first-page":"e19593","DOI":"10.7554\/eLife.19593","article-title":"Epidermal cell turnover across tight junctions based on Kelvin\u2019s tetrakaidecahedron cell shape","volume":"5","author":"Yokouchi","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.alit.2021.11.006_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/1523-1747.ep12482234","article-title":"A\u00a0liquid film model of tetrakaidecahedral packing to account for the establishment of epidermal cell columns","volume":"66","author":"Menton","year":"1976","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/aja.1001450102","article-title":"A\u00a0minimum-surface mechanism to account for the organization of cells into columns in the mammalian epidermis","volume":"145","author":"Menton","year":"1976","journal-title":"Am J Anat"},{"key":"10.1016\/j.alit.2021.11.006_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/264545a0","article-title":"Significance of cell shape in tissue architecture","volume":"264","author":"Allen","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.alit.2021.11.006_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0923-1811(93)90767-J","article-title":"A\u00a0speculative view of atopic dermatitis: barrier dysfunction in pathogenesis","volume":"5","author":"Ogawa","year":"1993","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI117408","article-title":"Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis","volume":"94","author":"Hamid","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2021.11.006_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2249.1991.tb02951.x","article-title":"Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis","volume":"86","author":"Reinhold","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00412924","article-title":"The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis","volume":"278","author":"Bruynzeel-Koomen","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.alit.2021.11.006_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.11.006_bib41","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.11.006_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.19574","article-title":"Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)","volume":"184","author":"Wollenberg","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib44","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2018.01.017","article-title":"Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: a randomized, placebo-controlled phase II trial (TREBLE)","volume":"78","author":"Simpson","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamadermatol.2020.0079","article-title":"Efficacy and safety of lebrikizumab, a high-affinity Interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: a phase 2b randomized clinical trial","volume":"156","author":"Guttman-Yassky","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-Interleukin-31 receptor A antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.11.006_bib47","author":"Kabashima","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbalip.2013.11.006","article-title":"The important role of stratum corneum lipids for the cutaneous barrier function","volume":"1841","author":"van Smeden","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.alit.2021.11.006_bib49","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/bjd.12908","article-title":"Lipid to protein ratio plays an important role in the skin barrier function in patients with atopic eczema","volume":"170","author":"Janssens","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib50","doi-asserted-by":"crossref","first-page":"eaau0683","DOI":"10.1126\/scitranslmed.aau0683","article-title":"Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment","volume":"11","author":"Matthias","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.alit.2021.11.006_bib51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jdermsci.2021.04.007","article-title":"Atopic dermatitis: role of the skin barrier, environment, microbiome, and therapeutic agents","volume":"102","author":"Luger","year":"2021","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib52","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2020.02.021","article-title":"Cutaneous barrier dysfunction in allergic diseases","volume":"145","author":"Leung","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.alit.2021.11.006_bib53","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jaci.2021.10.022","article-title":"Advances in atopic dermatitis in 2019-2020: endotypes from skin barrier, ethnicity, properties of antigen, cytokine profiles, microbiome, and engagement of immune cells","volume":"148","author":"Nomura","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib54","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/gb-2007-8-6-r107","article-title":"Large-scale identification of human genes implicated in epidermal barrier function","volume":"8","author":"Toulza","year":"2007","journal-title":"Genome Biol"},{"key":"10.1016\/j.alit.2021.11.006_bib55","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1600-0625.2012.01472.x","article-title":"The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family","volume":"21","author":"Kypriotou","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2133.2005.06352.x","article-title":"Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope","volume":"152","author":"Sugiura","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib57","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.2009.09582.x","article-title":"FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics","volume":"162","author":"Akiyama","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.alit.2021.11.006_bib59","doi-asserted-by":"crossref","first-page":"e98235","DOI":"10.1371\/journal.pone.0098235","article-title":"Filaggrin gene mutation c.3321delA is associated with various clinical features of atopic dermatitis in the Chinese Han population","volume":"9","author":"Meng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2021.11.006_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.10-RAI-0270","article-title":"Filaggrin gene defects and the risk of developing allergic disorders","volume":"60","author":"Osawa","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2021.11.006_bib61","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"Irvine","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.11.006_bib62","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2008.02.014","article-title":"Filaggrin mutations, atopic eczema, hay fever, and asthma in children","volume":"121","author":"Weidinger","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib63","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1398-9995.2010.02493.x","article-title":"Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib64","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","article-title":"Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis","volume":"124","author":"Guttman-Yassky","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib65","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/jid.2011.90","article-title":"Association screening in the Epidermal Differentiation Complex (EDC) identifies an SPRR3 repeat number variant as a risk factor for eczema","volume":"131","author":"Marenholz","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2340\/00015555-2301","article-title":"Association of a single nucleotide polymorphism in a late cornified envelope-like proline-rich 1 gene (LELP1) with atopic dermatitis","volume":"96","author":"Trzeciak","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2021.11.006_bib67","doi-asserted-by":"crossref","first-page":"adv00163","DOI":"10.2340\/00015555-3513","article-title":"Genetics in atopic dermatitis: historical perspective and future prospects","volume":"100","author":"Brown","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2021.11.006_bib68","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaci.2013.09.015","article-title":"Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects","volume":"133","author":"Margolis","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib69","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0022-2275(20)39952-1","article-title":"6-Hydroxy-4-sphingenine in human epidermal ceramides","volume":"35","author":"Robson","year":"1994","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.alit.2021.11.006_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2008.01.002","article-title":"Omega-O-acylceramide, a lipid essential for mammalian survival","volume":"51","author":"Uchida","year":"2008","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00015559850135788","article-title":"Ceramide and cholesterol composition of the skin of patients with atopic dermatitis","volume":"78","author":"Di Nardo","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2021.11.006_bib72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000441540","article-title":"Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients","volume":"49","author":"van Smeden","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib73","doi-asserted-by":"crossref","first-page":"e98006","DOI":"10.1172\/jci.insight.98006","article-title":"Lipid abnormalities in atopic skin are driven by type 2 cytokines","volume":"3","author":"Berdyshev","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.alit.2021.11.006_bib74","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.3390\/cells10092386","article-title":"The pathogenic and therapeutic implications of ceramide abnormalities in atopic dermatitis","volume":"10","author":"Fujii","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.alit.2021.11.006_bib75","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"124","author":"Howell","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib76","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrm1619","article-title":"The cornified envelope: a model of cell death in the skin","volume":"6","author":"Candi","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.alit.2021.11.006_bib77","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jaci.2015.04.042","article-title":"Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis","volume":"136","author":"Riethmuller","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib78","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1747.2000.00178.x","article-title":"Loss of normal profilaggrin and filaggrin in flaky tail (ft\/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris","volume":"115","author":"Presland","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib79","series-title":"Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models and Biomedical Tools","first-page":"269","article-title":"The flaky tail (ft) mutation","author":"Sundberg","year":"1994"},{"key":"10.1016\/j.alit.2021.11.006_bib80","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2009.05.042","article-title":"Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen","volume":"124","author":"Oyoshi","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib81","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.358","article-title":"A\u00a0homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming","volume":"41","author":"Fallon","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.alit.2021.11.006_bib82","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaci.2013.08.027","article-title":"A\u00a0homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis","volume":"132","author":"Sasaki","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib83","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jaci.2013.08.046","article-title":"Tmem79\/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects","volume":"132","author":"Saunders","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib84","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jaci.2012.01.068","article-title":"Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice","volume":"129","author":"Kawasaki","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib85","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.jid.2021.02.763","article-title":"Low threshold for cutaneous allergen sensitization but no spontaneous dermatitis or atopy in FLG-deficient mice","volume":"141","author":"Muhandes","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib86","doi-asserted-by":"crossref","first-page":"715611","DOI":"10.3389\/fphys.2021.715611","article-title":"Role of barrier integrity and dysfunctions in maintaining the healthy gut and their health outcomes","volume":"12","author":"Panwar","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.alit.2021.11.006_bib87","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1083\/jcb.201812157","article-title":"Claudins and JAM-A coordinately regulate tight junction formation and epithelial polarity","volume":"218","author":"Otani","year":"2019","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.alit.2021.11.006_bib88","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2012.06554.x","article-title":"Barriers and more: functions of tight junction proteins in the skin","volume":"1257","author":"Kirschner","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib89","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ajpath.2017.02.006","article-title":"Tight junction proteins claudin-1 and occludin are important for cutaneous wound healing","volume":"187","author":"Volksdorf","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.alit.2021.11.006_bib90","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/JLB.5MR0120-230R","article-title":"Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases","volume":"107","author":"Sugita","year":"2020","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.alit.2021.11.006_bib91","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jaci.2020.04.010","article-title":"Epithelial barriers in allergy and asthma","volume":"145","author":"Hellings","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib92","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/bjd.12724","article-title":"Novel mutation in the CLDN1 gene in a Turkish family with neonatal ichthyosis sclerosing cholangitis (NISCH) syndrome","volume":"170","author":"Kirchmeier","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib93","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","article-title":"Tight junction defects in patients with atopic dermatitis","volume":"127","author":"De Benedetto","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib94","doi-asserted-by":"crossref","first-page":"e1336194","DOI":"10.1080\/21688370.2017.1336194","article-title":"Time- and dose-dependent claudin contribution to biological functions: lessons from claudin-1 in skin","volume":"5","author":"Tokumasu","year":"2017","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.alit.2021.11.006_bib95","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41598-020-58718-9","article-title":"Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently","volume":"10","author":"Bergmann","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2021.11.006_bib96","doi-asserted-by":"crossref","first-page":"G577","DOI":"10.1152\/ajpgi.00439.2005","article-title":"Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed","volume":"290","author":"Shen","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.alit.2021.11.006_bib97","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jid.2019.06.145","article-title":"Peptides derived from the tight junction protein CLDN1 disrupt the skin barrier and promote responsiveness to an epicutaneous vaccine","volume":"140","author":"Brewer","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib98","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/jdv.13806","article-title":"The tight junction gene Claudin-1 is associated with atopic dermatitis among Ethiopians","volume":"30","author":"Asad","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2021.11.006_bib99","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jdermsci.2018.02.017","article-title":"IL-33 down-regulates CLDN1 expression through the ERK\/STAT3 pathway in keratinocytes","volume":"90","author":"Ryu","year":"2018","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib100","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/exd.14425","article-title":"Interferon-gamma downregulates tight junction function, which is rescued by interleukin-17A","volume":"30","author":"Mizutani","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib101","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.3390\/ijms20174070","article-title":"Antagonistic effects of IL-4 on IL-17A-mediated enhancement of epidermal tight junction function","volume":"20","author":"Brewer","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib102","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/jid.2012.437","article-title":"Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair","volume":"133","author":"Kuo","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib103","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.4049\/jimmunol.1100058","article-title":"Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes","volume":"187","author":"Yuki","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib104","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1600-0625.2011.01277.x","article-title":"Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients","volume":"20","author":"Niebuhr","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/exd.12383","article-title":"TLR2 and TLR4 expression in atopic dermatitis, contact dermatitis and psoriasis","volume":"23","author":"Panzer","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib106","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/ijms21030913","article-title":"Multifaceted analyses of epidermal serine protease activity in patients with atopic dermatitis","volume":"21","author":"Nomura","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib107","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jaci.2020.06.024","article-title":"Staphylococcus epidermidis protease EcpA can be a deleterious component of the skin microbiome in atopic dermatitis","volume":"147","author":"Cau","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaci.2018.01.007","article-title":"Activation of protease-activated receptor 2 leads to impairment of keratinocyte tight junction integrity","volume":"142","author":"Nadeau","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib109","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/exd.13936","article-title":"Update on protease-activated receptor 2 in cutaneous barrier, differentiation, tumorigenesis and pigmentation, and its role in related dermatologic diseases","volume":"28","author":"Henehan","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib110","doi-asserted-by":"crossref","first-page":"534501","DOI":"10.3389\/fimmu.2020.534501","article-title":"Insights into mucosal innate immune responses in house dust mite-mediated allergic asthma","volume":"11","author":"Abu Khweek","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib111","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00441-013-1558-1","article-title":"Netherton syndrome: skin inflammation and allergy by loss of protease inhibition","volume":"351","author":"Hovnanian","year":"2013","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.alit.2021.11.006_bib112","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/exd.14030","article-title":"House dust mite-treated PAR2 over-expressor mouse: a novel model of atopic dermatitis","volume":"28","author":"Smith","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jdermsci.2014.11.007","article-title":"Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum","volume":"77","author":"Yokouchi","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib114","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ajpath.2011.01.053","article-title":"Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function","volume":"178","author":"Gruber","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.alit.2021.11.006_bib115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2340\/0001555575429433","article-title":"Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin","volume":"75","author":"Seidenari","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2021.11.006_bib116","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities","volume":"127","author":"Suarez-Farinas","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib117","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2020.08.041","article-title":"Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities","volume":"147","author":"He","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib118","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature","volume":"82","author":"Pavel","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib119","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/all.13223","article-title":"Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues","volume":"72","author":"Brunner","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-4632.2011.05176.x","article-title":"Atopic dermatitis: correlation between non-damaged skin barrier function and disease activity","volume":"51","author":"Addor","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib121","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/cea.13866","article-title":"Sensitization to peanut, egg or pets is associated with skin barrier dysfunction in children with atopic dermatitis","volume":"51","author":"Sherenian","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib122","doi-asserted-by":"crossref","first-page":"eaav2685","DOI":"10.1126\/scitranslmed.aav2685","article-title":"The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype","volume":"11","author":"Leung","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.alit.2021.11.006_bib123","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaci.2018.11.015","article-title":"The microbiome in patients with atopic dermatitis","volume":"143","author":"Paller","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib124","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.3390\/ijms22168403","article-title":"The influence of microbiome dysbiosis and bacterial biofilms on epidermal barrier function in atopic dermatitis-An Update","volume":"22","author":"Blicharz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib125","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/bjd.18643","article-title":"The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group","volume":"182","author":"Alexander","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib126","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jid.2018.03.1517","article-title":"Patients with atopic dermatitis colonized with Staphylococcus aureus have a distinct phenotype and endotype","volume":"138","author":"Simpson","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib127","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01184-18","article-title":"Adhesion of Staphylococcus aureus to corneocytes from atopic dermatitis patients is controlled by natural moisturizing factor levels","volume":"9","author":"Feuillie","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.alit.2021.11.006_bib128","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014444118","article-title":"Staphylococcus aureus binds to the N-terminal region of corneodesmosin to adhere to the stratum corneum in atopic dermatitis","volume":"118","author":"Towell","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2021.11.006_bib129","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1111\/bjd.15409","article-title":"Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis","volume":"177","author":"Li","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib130","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jaci.2018.07.005","article-title":"Relations between epidermal barrier dysregulation and Staphylococcus species-dominated microbiome dysbiosis in patients with atopic dermatitis","volume":"142","author":"Altunbulakli","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.alit.2021.11.006_bib131","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jaci.2021.10.002","article-title":"Association between barrier impairment and skin microbiota in atopic dermatitis from a global perspective: unmet needs and open questions","volume":"148","author":"Darlenski","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib132","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2133.2010.10068.x","article-title":"Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age","volume":"163","author":"Flohr","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib133","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/jid.2008.280","article-title":"Clinical severity correlates with impaired barrier in filaggrin-related eczema","volume":"129","author":"Nemoto-Hasebe","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib134","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2010.04.038","article-title":"Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes","volume":"126","author":"O'Regan","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2340\/00015555-0329","article-title":"Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort","volume":"87","author":"Hubiche","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2021.11.006_bib136","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0190-9622(96)90495-8","article-title":"Skin reactivity to sodium lauryl sulfate in patients with respiratory atopy","volume":"35","author":"Seidenari","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib137","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2007.12.1161","article-title":"Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity","volume":"121","author":"Gupta","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib138","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.2011.10395.x","article-title":"The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis","volume":"165","author":"Danby","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib139","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.anai.2020.08.397","article-title":"Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin","volume":"126","author":"Lyubchenko","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/all.14490","article-title":"Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin","volume":"76","author":"Pavel","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib141","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2020.06.015","article-title":"Unique skin abnormality in patients with peanut allergy but no atopic dermatitis","volume":"147","author":"Berdyshev","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib142","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3389\/fimmu.2020.01768","article-title":"Tape-strip proteomic profiling of atopic dermatitis on dupilumab identifies minimally invasive biomarkers","volume":"11","author":"He","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib143","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamadermatol.2019.2983","article-title":"Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis","volume":"155","author":"Guttman-Yassky","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib144","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/bjd.16994","article-title":"A\u00a0minimally invasive tool to study immune response and skin barrier in children with atopic dermatitis","volume":"180","author":"Hulshof","year":"2019","journal-title":"Br J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.alit.2021.11.006_bib145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bjd.13245","article-title":"Electrical measurement of the hydration state of the skin surface in\u00a0vivo","volume":"171","author":"Tagami","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib146","first-page":"970","article-title":"The importance of acidification in atopic eczema: an underexplored avenue for treatment","volume":"4","author":"Panther","year":"2015","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.alit.2021.11.006_bib147","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1523-1747.2001.01258.x","article-title":"In\u00a0vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles","volume":"116","author":"Caspers","year":"2001","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib148","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1039\/D0AN02039G","article-title":"Raman microscopy for skin evaluation","volume":"146","author":"Egawa","year":"2021","journal-title":"Analyst"},{"key":"10.1016\/j.alit.2021.11.006_bib149","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.anai.2020.01.022","article-title":"In\u00a0vivo Raman spectroscopy discriminates between FLG loss-of-function carriers vs wild-type in day 1-4 neonates","volume":"124","author":"Ni Chaoimh","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.det.2017.06.009","article-title":"Electrical impedance spectroscopy in skin cancer diagnosis","volume":"35","author":"Braun","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.alit.2021.11.006_bib151","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1111\/all.14842","article-title":"Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis","volume":"76","author":"Rinaldi","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib152","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1084\/jem.20091527","article-title":"External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers","volume":"206","author":"Kubo","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.11.006_bib153","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/jid.2008.88","article-title":"Outside-to-inside\" (and now back to \"outside\") pathogenic mechanisms in atopic dermatitis","volume":"128","author":"Elias","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib154","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/jid.2011.435","article-title":"Skin barrier disruption: a requirement for allergen sensitization?","volume":"132","author":"De Benedetto","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib155","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/all.14318","article-title":"Type 2 immunity in the skin and lungs","volume":"75","author":"Akdis","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib156","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ni.2617","article-title":"TH2, allergy and group 2 innate lymphoid cells","volume":"14","author":"Licona-Limon","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib157","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1172\/JCI1647","article-title":"Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice","volume":"101","author":"Spergel","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2021.11.006_bib158","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1038\/s41598-019-44866-0","article-title":"Homeostatic pruning and activity of epidermal nerves are dysregulated in barrier-impaired skin during chronic itch development","volume":"9","author":"Takahashi","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2021.11.006_bib159","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2340\/00015555-1533","article-title":"Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial","volume":"93","author":"Jensen","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2021.11.006_bib160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0625.2008.00756.x","article-title":"Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis","volume":"18","author":"Aschoff","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib161","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaci.2009.03.032","article-title":"Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis","volume":"123","author":"Jensen","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib162","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaci.2019.06.047","article-title":"Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial","volume":"144","author":"Bissonnette","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib163","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2017.01.027","article-title":"Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis","volume":"140","author":"Guttman-Yassky","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib164","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2015.12.1306","article-title":"Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy","volume":"137","author":"Kim","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib165","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2014.10.013","article-title":"Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis","volume":"134","author":"Hamilton","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib166","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jid.2019.05.024","article-title":"IL-4Ralpha blockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis","volume":"140","author":"Callewaert","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib167","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib168","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/all.14664","article-title":"Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis","volume":"76","author":"Rohner","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.11.006_bib169","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4168\/aair.2021.13.5.762","article-title":"Dupilumab therapy improves stratum corneum hydration and skin dysbiosis in patients with atopic dermatitis","volume":"13","author":"Lee","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.alit.2021.11.006_bib170","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","article-title":"JAK inhibitors in the treatment of atopic dermatitis","volume":"148","author":"Chovatiya","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib171","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2015.03.051","article-title":"The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling","volume":"136","author":"Amano","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib172","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2019.07.013","article-title":"Oral Janus kinase\/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis","volume":"144","author":"Pavel","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib173","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2020.05.135","article-title":"Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis","volume":"84","author":"Paller","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib174","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.3390\/ijms20215424","article-title":"Aryl hydrocarbon receptor in atopic dermatitis and psoriasis","volume":"20","author":"Furue","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2021.11.006_bib175","first-page":"CD012119","article-title":"Emollients and moisturisers for eczema","volume":"2","author":"van Zuuren","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.alit.2021.11.006_bib176","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaci.2014.08.005","article-title":"Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention","volume":"134","author":"Simpson","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib177","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(19)32984-8","article-title":"Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial","volume":"395","author":"Chalmers","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2021.11.006_bib178","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/bjd.15747","article-title":"A\u00a0randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study","volume":"178","author":"Lowe","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.11.006_bib179","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jaci.2020.10.044","article-title":"Association of frequent moisturizer use in early infancy with the development of food allergy","volume":"147","author":"Perkin","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.11.006_bib180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(19)32983-6","article-title":"Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial","volume":"395","author":"Skjerven","year":"2020","journal-title":"Lancet"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893021001453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893021001453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:12:23Z","timestamp":1761156743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893021001453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":180,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1323893021001453"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2021.11.006","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin barrier defects in atopic dermatitis: From old idea to new opportunity","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}